{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:49:40Z","timestamp":1787827780090,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcp.2026.117894","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:44:15Z","timestamp":1773589455000},"page":"117894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nesfatin-1 attenuates renal interstitial fibrosis, oxidative stress, and inflammation through dual suppression of TGF-\u03b21\/Smad and NF-\u03baB\/GPR12 signaling"],"prefix":"10.1016","volume":"249","author":[{"given":"Ganesh Panditrao","family":"Lahane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-6875","authenticated-orcid":false,"given":"Arti","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.117894_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0015","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.kisu.2019.11.010","article-title":"Global case studies for chronic kidney disease\/end-stage kidney disease care","volume":"10","author":"Yang","year":"2020","journal-title":"Kidney Int. Suppl."},{"issue":"11","key":"10.1016\/j.bcp.2026.117894_b0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","article-title":"Diagnosis of cardiovascular disease in patients with chronic kidney disease","volume":"19","author":"Zoccali","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117894_b0025","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1007\/s00330-022-09329-7","article-title":"Evaluation of interstitial fibrosis in chronic kidney disease by multiparametric functional MRI and histopathologic analysis","volume":"33","author":"Mao","year":"2023","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2026.117894_b0035","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23795","article-title":"Therapeutic approaches and novel antifibrotic agents in renal fibrosis: a comprehensive review","volume":"38","author":"Lahane","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117894_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ackd.2016.11.002","article-title":"Treatment of renal fibrosis\u2014turning challenges into opportunities","volume":"24","author":"Klinkhammer","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"7","key":"10.1016\/j.bcp.2026.117894_b0045","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1002\/iid3.1335","article-title":"Pirfenidone use in fibrotic diseases: what do we know so far? Immunity","volume":"12","author":"Torre","year":"2024","journal-title":"Inflammation and Disease"},{"issue":"4","key":"10.1016\/j.bcp.2026.117894_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2014.14","article-title":"Potential approaches to reverse or repair renal fibrosis","volume":"10","author":"Tampe","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117894_b0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2026.117894_b0060","article-title":"Diabetes and kidney disease: role of oxidative stress","author":"JhaJay","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.bcp.2026.117894_b0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","article-title":"Reactive oxygen species and fibrosis: further evidence of a significant liaison","volume":"365","author":"Richter","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2026.117894_b0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/978-981-13-8871-2_29","article-title":"Oxidative stress and renal fibrosis: mechanisms and therapies","author":"Su","year":"2019","journal-title":"Renal Fibrosis: Mechanisms and Therapies"},{"key":"10.1016\/j.bcp.2026.117894_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120527","article-title":"Biochanin a alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-\u03b21\/Smad2\/3 and NF-kB\/NLRP3 signaling axis in mice","volume":"298","author":"Ram","year":"2022","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.117894_b0080","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/cells8111389","article-title":"The role of inflammasome-dependent and inflammasome-independent NLRP3 in the kidney","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.bcp.2026.117894_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70302","article-title":"Model systems of chronic kidney disease: a detailed overview and recent advances","volume":"39","author":"Lahane","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"39","key":"10.1016\/j.bcp.2026.117894_b0090","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.2174\/138161281939131127124149","article-title":"Phylogenetic aspects of nucleobindin-2\/nesfatin-1","volume":"19","author":"Mohan","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2026.117894_b0095","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s40200-022-01070-8","article-title":"Nesfatin-1 as a diagnosis regulatory peptide in type 2 diabetes mellitus","volume":"21","author":"Kadim","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"issue":"6","key":"10.1016\/j.bcp.2026.117894_b0100","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1080\/21655979.2022.2066748","article-title":"Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway","volume":"13","author":"Fan","year":"2022","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.bcp.2026.117894_b0105","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1111\/jcmm.16481","article-title":"Nesfatin\u20101 inhibits myocardial ischaemia\/reperfusion injury through activating Akt\/ERK pathway\u2010dependent attenuation of endoplasmic reticulum stress","volume":"25","author":"Su","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117894_b0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3892\/etm.2021.10265","article-title":"Protective role and molecular mechanism of action of Nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells","volume":"22","author":"Sun","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.117894_b0115","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/ndt\/gfac053","article-title":"Nesfatin-1 treatment preserves antioxidant status and attenuates renal fibrosis in rats with unilateral ureteral obstruction","volume":"37","author":"Tezcan","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2026.117894_b0120","article-title":"Renoprotective effect of Nesfatin-1 in adenine-induced chronic kidney disease: an in vitro and in vivo study","volume":"225","author":"Lahane","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117894_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171013","article-title":"Nesfatin-1 peptide protects rat renal epithelial cells against high glucose and H2O2 induced injury via inhibition of oxidative stress, apoptosis, and fibrosis","volume":"165","author":"Lahane","year":"2023","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.bcp.2026.117894_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70593","article-title":"Nucleobindin\u20102 derived multifunctional peptide nesfatin\u20101: renoprotective mechanisms and therapeutic promise","volume":"39","author":"Lahane","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bcp.2026.117894_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.740174","article-title":"Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor\u2013a systematic review","volume":"12","author":"Rupp","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117894_b0140","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fphar.2020.00628","article-title":"Advances in Neurobiology and Pharmacology of GPR12","volume":"11","author":"Allende","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117894_b0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","article-title":"GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol","volume":"40","author":"Laun","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.117894_b0150","article-title":"G protein-coupled receptor-mediated renal fibrosis: a key focus on kidney disease drug development","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-012-1287-x","article-title":"Involvement of GPR12 in the regulation of cell proliferation and survival","volume":"366","author":"Lu","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"17","key":"10.1016\/j.bcp.2026.117894_b0160","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.18632\/aging.103764","article-title":"Two identified subsets of CD8 T cells in obstructed kidneys play different roles in inflammation and fibrosis","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2026.117894_b0165","doi-asserted-by":"crossref","unstructured":"Lahane, G.P., A. Dhar, and A. Bhat, In-vitro Knockdown and Pharmacological Inhibition of RIPK2 Attenuates Calcium Oxalate\u2013Nephrocalcinosis Associated Inflammation and Oxidative Stress in NRK-52E and Primary Renal Epithelial Cells. bioRxiv, 2025: p. 2025.07. 13.664563.","DOI":"10.1101\/2025.07.13.664563"},{"issue":"2","key":"10.1016\/j.bcp.2026.117894_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114652","article-title":"PKR inhibition reduces high glucose and H2O2-induced injury in rat renal epithelial cells by suppressing the sonic hedgehog pathway","volume":"450","author":"Lahane","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.117894_b0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1535370214532597","article-title":"Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-\u03b2\/Smad signaling pathway in vivo and in vitro","volume":"239","author":"Wang","year":"2014","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.117894_b0180","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/jf304768p","article-title":"Dihydroquercetin (DHQ) induced HO-1 and NQO1 expression against oxidative stress through the Nrf2-dependent antioxidant pathway","volume":"61","author":"Liang","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2026.117894_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119241","article-title":"Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3\/NF-\u03baB signaling, oxidative stress and inflammation","volume":"272","author":"Hassan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117894_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2021.05.034","article-title":"Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis","volume":"172","author":"Aranda-Rivera","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117894_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174479","article-title":"Nootkatone confers antifibrotic effect by regulating the TGF-\u03b2\/Smad signaling pathway in mouse model of unilateral ureteral obstruction","volume":"910","author":"Gairola","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117894_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177162","article-title":"SR9009 attenuates TGF-\u03b21-induced renal fibrotic responses by inhibiting the NOX4\/p38 signaling pathway in NRK-49F cells","volume":"987","author":"Takaguri","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2026.117894_b0205","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1111\/bph.14333","article-title":"Novel inhibitors of the cellular renin\u2010angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt\/\u03b2\u2010catenin pathway against renal fibrosis","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117894_b0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/nep.12831","article-title":"Pirfenidone suppresses MAPK signalling pathway to reverse epithelial\u2010mesenchymal transition and renal fibrosis","volume":"22","author":"Li","year":"2017","journal-title":"Nephrology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.1998.00962.x","article-title":"Pirfenidone improves renal function and fibrosis in the post-obstructed kidney","volume":"54","author":"Shimizu","year":"1998","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bcp.2026.117894_b0220","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000081706","article-title":"Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats","volume":"24","author":"Gon\u00e7alves","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bcp.2026.117894_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110369","article-title":"Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-\u03b21\/Smad pathway in an AMPK\u03b1-dependent manner","volume":"120","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13019-022-01952-1","article-title":"Nesfatin-1 alleviated lipopolysaccharide-induced acute lung injury through regulating inflammatory response associated with macrophages modulation","volume":"17","author":"Cheng","year":"2022","journal-title":"J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.bcp.2026.117894_b0235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2613.2010.00730.x","article-title":"Oxidative stress in obstructive nephropathy","volume":"92","author":"Dendooven","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117894_b0240","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1002\/ptr.7137","article-title":"A review on herbal Nrf2 activators with preclinical evidence in cardiovascular diseases","volume":"35","author":"Syed","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.117894_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153185","article-title":"Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway","volume":"69","author":"Wang","year":"2020","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bcp.2026.117894_b0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10989-022-10429-7","article-title":"Modulation of apoptosis and oxidative stress with nesfatin-1 in doxorubicin induced cardiotoxicity in male rat","volume":"28","author":"Rakhshan","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11011-018-0323-2","article-title":"Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses","volume":"34","author":"Erfani","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jss.2014.06.057","article-title":"Nesfatin-1 alleviates gastric damage via direct antioxidant mechanisms","volume":"193","author":"Kolgazi","year":"2015","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117894_b0265","first-page":"741","article-title":"Anti-inflammatory effects of nesfatin-1 in rats with acetic acid-induced colitis and underlying mechanisms","volume":"66","author":"Ozturk","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117894_b0270","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","volume":"78","author":"Lee","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.117894_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1335094","article-title":"The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis","volume":"14","author":"Ren","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117894_b0280","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ndt\/gft332","article-title":"Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis","volume":"29","author":"Lorenz","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bcp.2026.117894_b0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.21037\/atm.2020.02.12","article-title":"Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway","volume":"8","author":"Qi","year":"2020","journal-title":"Ann. Trans. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.peptides.2012.04.014","article-title":"The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain","volume":"36","author":"Tang","year":"2012","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.bcp.2026.117894_b0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.59278\/cbs.v4i10.65","article-title":"Bax\/Bcl-2 Ratio as the Golden Marker of Apoptosis: Molecular Mechanisms and Regulatory Pathways","volume":"4","author":"Putri","year":"2025","journal-title":"Int. J. Cell Biomed. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117894_b0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12031-018-1105-3","article-title":"Nesfatin-1 improve spatial memory impairment following transient global cerebral ischemia\/reperfusion via inhibiting microglial and caspase-3 activation","volume":"65","author":"Erfani","year":"2018","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117894_b0310","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3109\/0886022X.2015.1015426","article-title":"The protective effect of nesfatin-1 against renal ischemia\u2013reperfusion injury in rats","volume":"37","author":"Jiang","year":"2015","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40709-021-00147-4","article-title":"Nesfatin-1 protects H9c2 cardiomyocytes against cobalt chloride-induced hypoxic injury by modulating the MAPK and Notch1 signaling pathways","volume":"28","author":"Li","year":"2021","journal-title":"J. Biol. Res. Thessaloniki"},{"issue":"8","key":"10.1016\/j.bcp.2026.117894_b0320","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41374-022-00774-y","article-title":"Nesfatin-1 exerts protective effects on acidosis-stimulated chondrocytes and rats with adjuvant-induced arthritis by inhibiting ASIC1a expression","volume":"102","author":"Xu","year":"2022","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2026.117894_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103698","article-title":"Opportunities and challenges in drug discovery targeting the orphan receptor GPR12","volume":"28","author":"Wang","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.bcp.2026.117894_b0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-023-01427-2","article-title":"G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders","volume":"8","author":"Wong","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:10:53Z","timestamp":1778710253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"alternative-id":["S0006295226002273"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117894","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nesfatin-1 attenuates renal interstitial fibrosis, oxidative stress, and inflammation through dual suppression of TGF-\u03b21\/Smad and NF-\u03baB\/GPR12 signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117894"}}